Scarica l'app Stockscreener
22.93
1.04%
-0.24
Dopo l'orario di chiusura:
22.93
Sanara Medtech Inc Borsa (SMTI) Ultime notizie
Sanara MedTech Dips After Swing to Profit - Bez Kabli
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire
Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser
Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesEarnings Call Q&A - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - PR Newswire
Pomerantz LLP investigates Sanara MedTech for p... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sanara MedTech (SMTI) CEO reports share withholding to cover tax on vested stock - Stock Titan
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Gr - The National Law Review
The Technical Signals Behind (SMTI) That Institutions Follow - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
2026-05-15 | Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Stockholders to Inquire about Securities Investigation | NDAQ:SMTI | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Investors to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Investors to Reach Out - ACCESS Newswire
Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2026 Earnings Call Transcript - Insider Monkey
Sanara MedTech Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook - MSN
Lake Street Maintains Sanara MedTech(SMTI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛
Sanara MedTech (SMTI) posts Q1 2026 profit as revenue reaches $27.8M - Stock Titan
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Sanara MedTech (SMTI) Reports Strong Q1 Revenue Growth and Impro - GuruFocus
2026-05-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out | NDAQ:SMTI | Press Release - Stockhouse
Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges - Investing.com
Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges By Investing.com - Investing.com South Africa
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call - Benzinga
Sanara MedTech Sees 2Q Rev $28.5M-$29.5M >SMTI - Moomoo
Sanara MedTech Q1 2026 Earnings Call Transcript - MarketBeat
Sanara MedTech's Surgical Pivot Delivers Q1 Profitability - BriefGlance
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Sanara Medtech earnings beat by $0.08, revenue topped estimates - Investing.com Canada
Is Sanara MedTech (SMTI) Undervalued After a Q1 2026 Earnings Be - GuruFocus
Sanara MedTech Reports Q1 2026: Revenue $27.8M, GAAP Net Income $0.05/share, Adjusted EBITDA $4.3M - TradingView
Sanara MedTech Q1 revenue rises, swings to profit - TradingView
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara MedTech Backs 2026 Rev $116M-$121M >SMTI - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Connect - ACCESS Newswire
2026-05-11 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Connect | NDAQ:SMTI | Press Release - Stockhouse
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Report Preview: What To Expect - GuruFocus
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-05-10 | Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:SMTI | Press Release - Stockhouse
Sanara Medtech Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach - MSN
Sanara MedTech faces securities fraud probe after $31.2M loss and program shutdown. - Pluang
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
2,804 SMTI restricted shares granted to controller Ashley Mackey - Stock Titan
How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target - Yahoo Finance
SMTI SEC FilingsSanara Medtech Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Precision Trading with Sanara Medtech Inc. (SMTI) Risk Zones - Stock Traders Daily
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - AOL.com
1.04%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):